Search is Powered by Google
Cancer / Oncology News

December Is Cancer-Related Fatigue Awareness Month

Main Category: Cancer / Oncology
Article Date: 25 Nov 2008 - 0:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article


Current Article Ratings:

Patient / Public:5 stars

4.67 (3 votes)

Health Professional:not yet rated

Article Opinions: 0 posts

Between 70 and 100 percent of cancer patients receiving treatment have fatigue, according to the American Cancer Society. Up to one-half of all survivors have reported fatigue lasting months or even years after treatment. Cancer related fatigue is one of the most distressing side effects of cancer and can affect personal relationships, one's sense of well-being, and even compliance with treatment. The Cancer Institute of New Jersey (CINJ) is making experts available to discuss the symptoms, signs, and causes of cancer-related fatigue during this Cancer-Related Fatigue Awareness Month. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

Signs of cancer-related fatigue include feeling tired or exhausted even after sleep, having trouble concentrating, feeling unmotivated, and lacking interest in normal day-today activities. Cancer fatigue is very different from the fatigue of everyday life, because it is not relieved by rest and often hits unexpectedly, thus affecting a person's ability to perform ordinary tasks. Many patients believe that fatigue is a side effect from treatment that cannot be managed. Although there is no cure for cancer-related fatigue, there are ways to cope and reduce symptoms.

CINJ experts available for comment include:

Regina S. Cunningham, PhD, RN, AOCN, is the chief nursing officer at CINJ and assistant professor of family medicine at UMDNJ-Robert Wood Johnson Medical School, who can discuss the issue of "cancer survivorship." Her research focuses on the transition of survivors back into the primary care setting. She also has an interest in the role of oncology nurses in influencing the outcomes of care in patients receiving cancer treatment, including the impact of cancer-related fatigue.

Beth Knox, MSN, RN, APN, AOCN, is an adult oncology certified nurse practitioner at CINJ, who practices in the Phase I clinical trial study group. She can discuss the multidisciplinary approach used at CINJ to assess cancer-related fatigue and fatigue associated with cancer chemotherapy treatments. Her research focuses on reducing chemotherapy-induced fatigue through promotion of communication about fatigue.

Barbara Hale, MSW, LCSW, is the manager of the Social Work Department at CINJ and the leader for the Living with Cancer-Patient and Family Support Group. She can provide information and strategies on how family members can help loved ones with cancer cope with the effects of cancer-related fatigue.

Cancer Institute of New Jersey
New Brunswick
NJ 08901
United States
http://www.cinj.org




Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Understanding And Treating Triple-Negative Breast Cancer
07 Jan 2009
Triple-negative breast cancer is a subtype of breast cancer that is clinically negative for expression of estrogen and progesterone receptors (ER/PR) and HER2 protein. It is characterized by its unique molecular profile...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...